Overall, it emerges that tau protein leaking from the brain into the peripheral circulatory system is subjected to fast degradation and elimination by endogenous tau-reactive antibodies, a process which seems to be compromised in AD (Figure 1). This evidence concerns the gene MAPT and Alzheimer disease.